logo

Sierra Oncology, Inc. (SRRA)



Trade SRRA now with
  Date
  Headline
6/17/2022 7:02:30 AM Sierra Oncology Submits NDA For Momelotinib To FDA
4/13/2022 2:03:08 AM GSK Agrees To Buy Sierra Oncology For $1.9 Bln
7/7/2021 7:15:51 AM Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/23/2021 7:01:17 AM Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
6/21/2021 7:06:26 AM Sierra Oncology Completes Enrollment For MOMENTUM Phase 3 Trial; Topline Data Anticipated In Q1
6/3/2021 7:07:48 AM Sierra Oncology: Georgia Erbez And Christy Oliger Join To Its Board
5/21/2021 7:01:41 AM Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5/12/2021 10:05:50 AM Sierra Oncology Reports Oral Presentation At European Hematology Association Annual Meeting
5/7/2021 7:15:47 AM Sierra Oncology Q1 Loss Per Share $1.71 Vs Loss Per Share $3.14 Year Ago
3/11/2021 7:14:36 AM Sierra Oncology 2020 Non-GAAP Adjusted Net Loss $53.7 Mln Vs Non-GAAP Adjusted Net Loss $51.2 Mln Last Year
3/11/2021 7:00:00 AM Sierra Oncology Reports 2020 Year End Results (Press Release)
2/12/2021 7:29:43 AM Sierra Oncology Announces Presentation At LifeSci Partners Precision Oncology Day
5/9/2019 10:06:04 AM Wedbush Is Increasing Sierra Oncology, Inc. (SRRA) FY19 Estimate To -0.77 From -0.84
5/9/2019 10:05:52 AM Wedbush Is Increasing Sierra Oncology, Inc. (SRRA) Q4 19 Estimate To -0.21 From -0.22
5/9/2019 10:05:39 AM Wedbush Is Raising Sierra Oncology, Inc. (SRRA) Q3 19 Estimate To -0.20 From -0.22
5/9/2019 10:05:21 AM Wedbush Is Raising Sierra Oncology, Inc. (SRRA) Q2 19 Estimate To -0.19 From -0.21